Skip to content
Research ReviewEditorially reviewedFact-checked October 2026

Iron Deficiency Without Anemia: What the Trials Show

Hemoglobin normal, ferritin low, and exhausted: some clinicians dismiss it and supplement sellers promise everything. The randomized trials land in between. A modest, real effect on fatigue at low ferritin, a defensible case for restless legs, mixed exercise data and nothing solid for hair.

Evidence strength

Level 1a

Systematic review of RCTs

Peer-reviewed refs

25

Reading time

11 min

Compounds:ironvitamin-c

Key Takeaways

  • Fatigue is the best-supported indication. A meta-analysis of four trials found an effect of SMD −0.38, and oral iron cut fatigue by 47.7% versus 28.8% on placebo in women with ferritin below 50. The effect is real and modest.
  • Not every trial agrees. Iron had no effect on fatigue in 154 female blood donors, and IV iron was only clearly better in women who started at 15 ng/mL or below.
  • Restless legs has the most specific case: a Cochrane review found an improvement of 3.78 points on the severity scale, and a 2025 guideline recommends iron at ferritin 75 or below. The guideline itself calls those thresholds untested.
  • Exercise evidence is split. One meta-analysis of endurance athletes was positive, a review limited to randomized trials found no effect on VO2max, and every positive study in a third review used ferritin of 20 or below.
  • We found no randomized trial showing iron regrows hair, and in a controlled study iron deficiency was no more common in women with hair loss than in those without.
  • None of this supports iron for people with adequate stores. Confirm the deficiency first, find its cause, and set a retest date.

Hemoglobin normal, ferritin 22, and too tired to get through the afternoon. Some clinicians will call that result fine. Supplement marketing will blame it for fatigue, brain fog, hair loss and poor workouts. In a cohort of 784,132 Ontario women, most of whom had been tested, 38.3% met the definition of iron deficiency without anemia, so a great many people are getting one of those two answers.

The randomized trials fit neither. They show a modest effect on fatigue that is clearest at low ferritin, a reasonable case for restless legs, mixed results for exercise and very little for hair. This review goes through each. For how the cut-offs work, start with Ferritin Levels: What Your Result Actually Means.

Fatigue: Real, Modest and Concentrated at Low Ferritin

Most of the evidence comes from women who menstruate.

StudyWhoTreatmentResult
2003, BMJ144 women with unexplained fatigueOral iron 80 mg/day, 4 weeksFatigue −29% vs −13%; improvement only at ferritin 50 or below
2012, CMAJ198 women, ferritin below 50Ferrous sulfate 80 mg/day, 12 weeksFatigue −47.7% vs −28.8%; no change in quality of life, depression or anxiety
2012, BMC Medicine154 female blood donorsFerrous sulfate, 4 weeksNo effect on fatigue, despite higher hemoglobin and ferritin
2011, Blood90 women, ferritin 50 or belowIV iron 800 mgNot significant overall (P=.07); clear benefit at ferritin 15 or below
2014, PLoS One290 womenIV iron 1,000 mgImproved 65.3% vs 52.7%; more adverse events

A systematic review of randomized trials pooled four fatigue studies and found an effect of SMD −0.38, which is small to moderate.

Three limits matter when you read that figure:

  • The outcome is subjective and placebo effects are large. More than half of the placebo group improved in the 2014 trial, which was single-blind.
  • The ferritin threshold is soft. The 50 ng/mL line comes from entry criteria and subgroups, so it wasn't tested as a treatment target.
  • Other outcomes barely moved. Quality of life didn't change in the 2012 CMAJ trial, and it was also unchanged across IV trials in a 2022 review.

A Cochrane review of IV iron in non-anemic adults went further, calling the evidence insufficient to show benefit. So a trial of iron is reasonable for a tired menstruating woman with low ferritin, as long as other causes have been looked at and the trial has an end date. It's not a cure for fatigue in general.

Restless Legs: The Most Specific Case

A Cochrane review of 10 studies with 428 participants found iron improved the restless legs severity score by 3.78 points (95% CI −6.25 to −1.31, moderate certainty). Sleep quality didn't clearly change, and subgroup analysis found no significant difference by low ferritin or by oral versus IV delivery.

The 2025 American Academy of Sleep Medicine guideline recommends oral or IV iron at ferritin 75 ng/mL or below, or saturation below 20%, and IV iron only at 75–100. That's far above the general deficiency cut-off, and the guideline says so openly: the thresholds are consensus, untested empirically and specific to this condition. It doesn't support a target of 75 for anyone else.

Exercise: Depends Who You Ask

Three reviews disagree, largely because they ask slightly different questions.

  • Positive. A 2015 meta-analysis of 17 studies in endurance athletes found improved VO2max (Hedges' g 0.61).
  • Null. The 2018 review limited to randomized trials found no effect on VO2max (SMD 0.11, CI −0.15 to 0.37).
  • Split evenly. A 2018 review of 12 studies found six positive and six null. All six positive studies used a ferritin cut-off of 20 or below.

A fair reading: a benefit is plausible when athletes are truly depleted, and there's little to expect at higher levels. An athlete with ferritin of 40 hoping for a faster time has no good trial behind them.

Cognition: An Attention Signal

A meta-analysis of 14 small trials in children aged 6 and over, adolescents and women found improved attention (SMD 0.59), with IQ benefits only in those who were anemic and no effect on memory, psychomotor skills or school achievement. It found no trials in men or older people. A small trial in iron-deficient teenage girls found better verbal learning and memory. A 2025 meta-analysis in non-anemic children, adolescents and menstruating adults reported effects on anxiety, fatigue and short-term memory in its randomized trials, with no effect on attention or depression.

Those results aren't consistent enough to promise anything. A possible cognitive benefit is a side reason to correct a confirmed deficiency, and it's no reason to take iron on spec.

Hair: Weakest of All

Iron is often the first thing recommended for shedding, but the data don't support that. In a controlled study of 381 women with pattern hair loss or chronic shedding and 76 controls, iron deficiency was not more common in the hair-loss groups. At ferritin of 15 or below, premenopausal rates were 12.4% and 12.1% versus 29.8% in controls. Those authors noted that the effect of correcting deficiency on hair loss was unknown, and an earlier review found insufficient evidence for treating hair loss with iron in women without anemia.

We found no randomized trial showing that iron regrows hair in non-anemic people. Check ferritin in women with hair loss because deficiency is common and worth fixing on its own merits; see the hair retention protocol. Don't count on it to bring hair back.

Heart Failure: Don't Borrow the Evidence

IV iron trials in heart failure are often cited to support iron for energy generally. They don't transfer. In IRONOUT HF, oral iron failed to improve exercise capacity (difference 21 mL/min, P=.46) in 225 patients. HEART-FID, testing IV ferric carboxymaltose in 3,065 patients, narrowly missed its prespecified threshold (win ratio 1.10, 99% CI 0.99–1.23). These are sick people on specific treatments, and none of it says anything about a supplement in a healthy adult.

Oral or IV?

IV iron works faster and bypasses the gut, but it brings its own risks. In a 2020 pair of randomized trials, ferric carboxymaltose caused low phosphate in 74–75% of patients, compared with about 8% on iron isomaltoside. A meta-analysis of 42 trials found 47% versus 4%. In the 2011 fatigue trial above, drug-related adverse events were 21% versus 7%. IV iron makes sense under medical care when oral iron fails or isn't tolerated, and it's not a wellness infusion.

The Scorecard

SymptomEvidenceGradePractical reading
Fatigue, menstruating womenSeveral RCTs, one meta-analysisBReasonable 12-week trial if ferritin is below 30, or below 50 with no other explanation
Restless legsCochrane, guidelineB for iron, C for thresholdsReasonable at ferritin 75 or below, with a clinician
Exercise performanceMixedCOnly if clearly depleted (about 20 or below)
CognitionMixed, smallCNot a reason on its own
HairNo trials foundDTest and correct, but don't expect regrowth

What About People With Adequate Stores?

There's no case for it, and some reason for caution. We found no trials testing clinical harm in people with adequate stores, so the signal is observational and limited. In the Iowa Women's Health Study of 38,772 older women, iron supplement use was associated with higher mortality (HR 1.10), though that can't separate treated deficiency from routine use. In the Framingham elderly cohort, 30 mg/day or more of supplemental iron was associated with over four times the odds of high iron stores.

The physiology points the same way. Absorption rose only when ferritin fell below about 50 in healthy young women, and stayed stable above that, so stores above that point aren't calling for more.

What This Means in Practice

  1. Test first: ferritin, transferrin saturation, blood count and CRP.
  2. Find the cause. Heavy periods, diet, donation, acid suppression and celiac disease are common. In men and postmenopausal women, see a doctor about possible blood loss.
  3. Treat a confirmed deficiency with a defined course. Doses and schedule are in the Iron Repletion Protocol.
  4. Set the expectation and an end date. Retest at 8–12 weeks. If symptoms haven't changed once ferritin has, the cause was probably elsewhere. Thyroid problems are one thing to check; see the subclinical hypothyroidism review.

Frequently Asked Questions

Can low ferritin cause fatigue with normal hemoglobin? It can contribute. Randomized trials show modest improvement with iron, mainly below 50 ng/mL, but placebo responses are large and fatigue has many causes.

How long until iron helps fatigue? Trials measured results at 4–12 weeks, with benefit seen in that window. If nothing has changed after 12 weeks and ferritin has risen, look elsewhere.

Will iron help my hair grow back? We found no trial showing that. Correct a confirmed deficiency for general health, and treat the hair loss on its own terms.

Should athletes take iron routinely? No. Test first. The positive performance studies involved athletes with ferritin of 20 or below.

Is IV iron better for fatigue? It raises iron faster, but the fatigue results aren't clearly better, and it carries infusion and low-phosphate risks. It belongs under medical supervision.

Related Research

Scientific References

  1. [1]
    Wen S, Nisenbaum R, Weyand AC, et al.. High prevalence of iron deficiency and socioeconomic disparities in laboratory screening of non-pregnant females of reproductive age: A retrospective cohort study — American Journal of Hematology (2024)Oxford 2b
    PMID 38695834
  2. [2]
    Houston BL, Hurrie D, Graham J, et al.. Efficacy of iron supplementation on fatigue and physical capacity in non-anaemic iron-deficient adults: a systematic review of randomised controlled trials — BMJ Open (2018)Oxford 1a
    PMID 29626044
  3. [3]
    Verdon F, Burnand B, Stubi CL, et al.. Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial — BMJ (2003)Oxford 1b
    PMID 12763985
  4. [4]
    Vaucher P, Druais PL, Waldvogel S, et al.. Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial — CMAJ (2012)Oxford 1b
    PMID 22777991
  5. [5]
    Waldvogel S, Pedrazzini B, Vaucher P, et al.. Clinical evaluation of iron treatment efficiency among non-anemic but iron-deficient female blood donors: a randomized controlled trial — BMC Medicine (2012)Oxford 1b
    PMID 22272750
  6. [6]
    Krayenbuehl PA, Battegay E, Breymann C, et al.. Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration — Blood (2011)Oxford 1b
    PMID 21705493
  7. [7]
    Favrat B, Balck K, Breymann C, et al.. Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women--PREFER a randomized, placebo-controlled study — PLoS One (2014)Oxford 1b
    PMID 24751822
  8. [8]
    Miles LF, Litton E, Imberger G, et al.. Intravenous iron therapy for non-anaemic, iron-deficient adults — Cochrane Database of Systematic Reviews (2019)Oxford 1a
    PMID 31860749
  9. [9]
    Dugan C, Cabolis K, Miles LF, et al.. Systematic review and meta-analysis of intravenous iron therapy for adults with non-anaemic iron deficiency: An abridged Cochrane review — Journal of Cachexia, Sarcopenia and Muscle (2022)Oxford 1a
    PMID 36321348
  10. [10]
    Trotti LM, Becker LA. Iron for the treatment of restless legs syndrome — Cochrane Database of Systematic Reviews (2019)Oxford 1a
    PMID 30609006
  11. [11]
    Winkelman JW, Berkowski JA, DelRosso LM, et al.. Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline — Journal of Clinical Sleep Medicine (2025)Oxford 5
    PMID 39324694
  12. [12]
    Burden RJ, Morton K, Richards T, et al.. Is iron treatment beneficial in, iron-deficient but non-anaemic (IDNA) endurance athletes? A systematic review and meta-analysis — British Journal of Sports Medicine (2015)Oxford 1a
    PMID 25361786
  13. [13]
    Rubeor A, Goojha C, Manning J, et al.. Does Iron Supplementation Improve Performance in Iron-Deficient Nonanemic Athletes? — Sports Health (2018)Oxford 2a
    PMID 29792778
  14. [14]
    Falkingham M, Abdelhamid A, Curtis P, et al.. The effects of oral iron supplementation on cognition in older children and adults: a systematic review and meta-analysis — Nutrition Journal (2010)Oxford 1a
    PMID 20100340
  15. [15]
    Bruner AB, Joffe A, Duggan AK, et al.. Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls — The Lancet (1996)Oxford 1b
    PMID 8855856
  16. [16]
    Fiani D, Chahine S, Zaboube M, et al.. Psychiatric and cognitive outcomes of iron supplementation in non-anemic children, adolescents, and menstruating adults: A meta-analysis and systematic review — Neuroscience and Biobehavioral Reviews (2025)Oxford 1a
    PMID 40945632
  17. [17]
    Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss — Journal of the American Academy of Dermatology (2006)Oxford 5
    PMID 16635664
  18. [18]
    Olsen EA, Reed KB, Cacchio PB, et al.. Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups — Journal of the American Academy of Dermatology (2010)Oxford 3
    PMID 20947203
  19. [19]
    Lewis GD, Malhotra R, Hernandez AF, et al.. Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial — JAMA (2017)Oxford 1b
    PMID 28510680
  20. [20]
    Mentz RJ, Garg J, Rockhold FW, et al.. Ferric Carboxymaltose in Heart Failure with Iron Deficiency — The New England Journal of Medicine (2023)Oxford 1b
    PMID 37632463
  21. [21]
    Wolf M, Rubin J, Achebe M, et al.. Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials — JAMA (2020)Oxford 1b
    PMID 32016310
  22. [22]
    Schaefer B, Tobiasch M, Viveiros A, et al.. Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside-a systematic review and meta-analysis — British Journal of Clinical Pharmacology (2021)Oxford 1a
    PMID 33188534
  23. [23]
    Mursu J, Robien K, Harnack LJ, et al.. Dietary supplements and mortality rate in older women: the Iowa Women's Health Study — Archives of Internal Medicine (2011)Oxford 2b
    PMID 21987192
  24. [24]
    Fleming DJ, Tucker KL, Jacques PF, et al.. Dietary factors associated with the risk of high iron stores in the elderly Framingham Heart Study cohort — The American Journal of Clinical Nutrition (2002)Oxford 3
    PMID 12450906
  25. [25]
    Galetti V, Stoffel NU, Sieber C, et al.. Threshold ferritin and hepcidin concentrations indicating early iron deficiency in young women based on upregulation of iron absorption — EClinicalMedicine (2021)Oxford 2b
    PMID 34401687

Follow us on Google Search

Add BiohackingHub as a preferred source to see more of our research in Google results.

Ad slot available · 728×90Advertise here

Related protocols

Partner with BiohackingHub

Editorial placements, sponsorships, and product features for evidence-minded brands.

Partnership opportunities →